Evidence map›Paper›PMID 42058779›Full record

ArticleFrontiers in endocrinology2026

Case Report: Abnormally low hemoglobin A1c in a diabetic patient with

Lili Ye, Qian Ren, Tianhao Ba, Jing Wu, Xueyao Han, Linong Ji

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lili Ye *Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Qian Ren *Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Tianhao BaDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Jing WuDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Xueyao HanDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Linong JiDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hemoglobin A1c (HbA1c) is a critical biomarker used for the diagnosis and management of diabetes. However, nonglycemic genetic variations may affect the accuracy of HbA1c measurements. Methods: We presented a clinical evaluation of a type 2 diabetic patient with an Results: A 56-year-old patient with type 2 diabetes presented with a low HbA1c level, an elevated glycated albumin percentage (GA), normal hemoglobin and albumin levels, hemolysis, and increased red blood cell osmotic fragility. Exome sequencing revealed a heterozygous mutation in Conclusions: We report the

Indexed as

Anion Exchange Protein 1, ErythrocyteDiabetes Mellitus, Type 2Glycated HemoglobinMutationSpherocytosis, HereditaryHumansMaleMiddle AgedAnion Exchange Protein 1, ErythrocyteGlycated Hemoglobinhemoglobin A1c protein, humanSLC4A1 protein, humandiabetesglycated albuminHbA1chemolytic anemiahereditary spherocytosisSLC4A1 gene

Identifiers

PMID42058779
PMCPMC13121054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.